Search

Search Constraints

You searched for: Author/Creator Poloni, A.

Search Results

1. 147 IN VITRO CULTURE OF BM CELLS AND CYTC POLYMORPHISMS CAN PREDICT THE "IN VIVO" HEMATOLOGICAL RESPONSE INDUCED BY DEFERASIROX. (April 2015)

2. 149 LOW RPS14 EXPRESSION IS FREQUENTLY FOUND IN NON-5Q-MYELODYSPLASTIC SYNDROMES. Issue 1 (April 2015)

3. A Real-Life Study of Deferasirox in Patients with Higher Risk Myelodysplastic Syndromes. (April 2017)

4. Different Repo Doses (High vs Standard) for Treatment of Anemia in MDS Patients: A Survey from the Italian MDS Registry. (April 2017)

5. Effects of Erythropoiesis-Stimulating Agents on Overall Survival of IPSS Low/INT-1 Risk Transfusion Independent Myelodysplastic Syndrome Patients, a FISM Study. (April 2017)

6. Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation: A MULTI-CENTER EXPERIENCE OF HYPOCELLULAR MYELODYSPLASTIC SYNDROMES (H-MDS): FROM CLINICAL DESCRIPTION TO IMMUNOLOGICAL CHARACTERIZATION. (September 2021)